+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Respiratory Drugs Market Research Reports

IgE Receptor Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

IgE Receptor Antagonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Integrin Alpha4beta1 Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

Integrin Alpha4beta1 Antagonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Neonatal Respiratory Distress Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Neonatal Respiratory Distress Syndrome - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
ARDS - Pipeline Insight, 2025 - Product Thumbnail Image

ARDS - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Idiopathic Pulmonary Fibrosis - Pipeline Insight, 2025 - Product Thumbnail Image

Idiopathic Pulmonary Fibrosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 250 Pages
  • Global
From
Acute Respiratory Distress Syndrome (ARDS) - Pipeline Insight, 2025 - Product Thumbnail Image

Acute Respiratory Distress Syndrome (ARDS) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 100 Pages
  • Global
From
Emphysema - Pipeline Insight, 2025 - Product Thumbnail Image

Emphysema - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Pleural Effusion - Pipeline Insight, 2025 - Product Thumbnail Image

Pleural Effusion - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Sinusitis - Pipeline Insight, 2025 - Product Thumbnail Image

Sinusitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
From
Sarcoidosis - Pipeline Insight, 2025 - Product Thumbnail Image

Sarcoidosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 75 Pages
  • Global
From
Bronchopulmonary Dysplasia - Pipeline Insight, 2025 - Product Thumbnail Image

Bronchopulmonary Dysplasia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Bronchiectasis - Pipeline Insight, 2025 - Product Thumbnail Image

Bronchiectasis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 70 Pages
  • Global
From
Bacterial Pneumonia - Pipeline Insight, 2025 - Product Thumbnail Image

Bacterial Pneumonia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Bronchitis - Pipeline Insight, 2025 - Product Thumbnail Image

Bronchitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Community-acquired Pneumonia (CAP) - Pipeline Insight, 2025 - Product Thumbnail Image

Community-acquired Pneumonia (CAP) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Acute Lung Injury - Pipeline Insight, 2025 - Product Thumbnail Image

Acute Lung Injury - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Alpha- Antitrypsin Deficiency - Pipeline Insight, 2025 - Product Thumbnail Image

Alpha- Antitrypsin Deficiency - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Community-Acquired Bacterial Pneumonia (CABP) - Pipeline Insight, 2025 - Product Thumbnail Image

Community-Acquired Bacterial Pneumonia (CABP) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Respiratory Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat respiratory diseases. These drugs are used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Commonly prescribed respiratory drugs include bronchodilators, corticosteroids, and antibiotics. The Respiratory Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include GlaxoSmithKline, AstraZeneca, Merck & Co., Novartis, and Boehringer Ingelheim. These companies are constantly researching and developing new drugs to treat respiratory diseases, as well as improving existing treatments. Show Less Read more